Skip to menu Skip to content Skip to footer

2016

Book Chapter

Cdc25 family phosphatases in cancer

Gabrielli, Brian and Burgess, Andrew (2016). Cdc25 family phosphatases in cancer. Protein tyrosine phosphatases in cancer. (pp. 283-306) edited by Benjamin G. Neel and Nicholas K. Tonks. New York, USA: Springer New York. doi: 10.1007/978-1-4939-3649-6_11

Cdc25 family phosphatases in cancer

2015

Book Chapter

Cell cycle checkpoint and DNA damage response defects as anticancer targets: from molecular mechanisms to therapeutic opportunities.

Spoerri, Loredana, Oo, Zay Yar, Larsen, Jill E., Haass, Nikolas K., Gabrielli, Brian and Pavey, Sandra (2015). Cell cycle checkpoint and DNA damage response defects as anticancer targets: from molecular mechanisms to therapeutic opportunities.. Stress response pathways in cancer: from molecular targets to novel therapeutics. (pp. 29-49) edited by Georg T. Wondrak. Dordrecht: Springer Science+Business Media. doi: 10.1007/978-94-017-9421-3_3

Cell cycle checkpoint and DNA damage response defects as anticancer targets: from molecular mechanisms to therapeutic opportunities.

2008

Book Chapter

Do Histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?

Gabrielli, Brian G., Stevens, Frances and Beamish, Heather J. (2008). Do Histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?. Checkpoint responses in cancer therapy. (pp. 291-309) edited by Wei Dai. The United States of America: Humana Press. doi: 10.1007/978-1-59745-274-8

Do Histone deacetylase inhibitors target cell cycle checkpoints that monitor heterochromatin structure?

2006

Book Chapter

Cell Cycle Targets of Histone Deacetylase Inhibitors

Gabrielli, Brian (2006). Cell Cycle Targets of Histone Deacetylase Inhibitors. Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions. (pp. 299-314) edited by Eric Verdin. Berlin: Humana Press.

Cell Cycle Targets of Histone Deacetylase Inhibitors

2005

Book Chapter

Histone Deacetylase Inhibition as a Treatment of TRAIL-Resistant Cancers

Neuzil, J., Andera, L. and Gabrielli, B. (2005). Histone Deacetylase Inhibition as a Treatment of TRAIL-Resistant Cancers. Application of Apoptosis to Cancer Treatment. (pp. 271-291) edited by Mels Sluyser. Netherlands: Springer. doi: 10.1007/1-4020-3302-8_12

Histone Deacetylase Inhibition as a Treatment of TRAIL-Resistant Cancers

2004

Book Chapter

Analysis of Checkpoint Responses to Histone Deacetylase Inhibitors

Beamish, Heather, Warrener, Robyn and Gabrielli, Brian G. (2004). Analysis of Checkpoint Responses to Histone Deacetylase Inhibitors. Checkpoint Controls and Cancer: Vol. 2: Activation and Regulation Protocols. (pp. 245-259) edited by Axel H. Schonthal. Totowa, N.J.: Humana Press. doi: 10.1226/1588295001

Analysis of Checkpoint Responses to Histone Deacetylase Inhibitors